(Q51181024)
Statements
Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men. (English)
1 reference
1 reference
1 reference
Greg D Gamble
1 reference
Andrew Grey
1 reference
Simon E Briggs
1 reference
Mark G Thomas
1 reference
Rod B Ellis-Pegler
1 reference
14 March 2012
1 reference
97
1 reference
6
1 reference
1922-1928
1 reference
Identifiers
1 reference